Citation: | Wang Ronggen, Ruan Miaomiao, Zhang Runjie, Chen Lei, Li Xiaoxue, Fang Bin, Li Chu, Ren Xueyang, Liu Jiying, Xiong Qiang, Zhang Lining, Jin Yong, Li Lin, Li Rongfeng, Wang Ying, Yang Haiyuan, Dai Yifan. Antigenicity of tissues and organs from GGTA1/CMAH/β4GalNT2 triple gene knockout pigs[J]. The Journal of Biomedical Research, 2019, 33(4): 235-243. DOI: 10.7555/JBR.32.20180018 |
[1] |
McGregor CGA, Byrne GW. Porcine to human heart transplantation: is clinical application now appropriate?[J]. J Immunol Res, 2017, 2017: 2534653.
|
[2] |
Patel MS, Louras N, Vagefi PA. Liver xenotransplantation[J]. Curr Opin Organ Transplant, 2017, 22(6): 535–540. doi: 10.1097/MOT.0000000000000459
|
[3] |
Shah JA, Patel MS, Elias N, et al. Prolonged survival following pig-to-primate liver xenotransplantation utilizing exogenous coagulation factors and costimulation blockade[J]. Am J Transplant, 2017, 17(8): 2178–2185. doi: 10.1111/ajt.2017.17.issue-8
|
[4] |
Iwase H, Kobayashi T. Current status of pig kidney xenotransplantation[J]. Int J Surg, 2015, 23(Pt B): 229–233.
|
[5] |
Fukui A, Yokoo T. Kidney regeneration using developing xenoembryo[J]. Curr Opin Organ Transplant, 2015, 20(2): 160–164. doi: 10.1097/MOT.0000000000000176
|
[6] |
Wilczek P, Lesiak A, Niemiec-Cyganek A, et al. Biomechanical properties of hybrid heart valve prosthesis utilizing the pigs that do not express the galactose-α-1,3-galactose (α-Gal) antigen derived tissue and tissue engineering technique[J]. J Mater Sci Mater Med, 2015, 26(1): 5329.
|
[7] |
Laird C, Burdorf L, Pierson RN 3rd. Lung xenotransplantation: a review[J]. Curr Opin Organ Transplant, 2016, 21(3): 272–278. doi: 10.1097/MOT.0000000000000311
|
[8] |
Sahara H, Watanabe H, Pomposelli T, et al. Lung xenotransplantation[J]. Curr Opin Organ Transplant, 2017, 22(6): 541–548. doi: 10.1097/MOT.0000000000000465
|
[9] |
Abalovich A, Matsumoto S, Wechsler CJ, et al. Level of acceptance of islet cell and kidney xenotransplants by personnel of hospitals with and without experience in clinical xenotransplantation[J]. Xenotransplantation, 2017, 24(4): 1–5.
|
[10] |
Cooper DKC, Matsumoto S, Abalovich A, et al. Progress in clinical encapsulated islet xenotransplantation[J]. Transplantation, 2016, 100(11): 2301–2308. doi: 10.1097/TP.0000000000001371
|
[11] |
Cooper DKC, Ekser B, Ramsoondar J, et al. The role of genetically engineered pigs in xenotransplantation research[J]. J Pathol, 2016, 238(2): 288–299. doi: 10.1002/path.4635
|
[12] |
Dong X, Hara H, Wang Y, et al. Initial study of 1,3- galactosyltransferase gene-knockout/CD46 pig full-thickness corneal xenografts in rhesus monkeys[J]. Xenotransplantation, 2017, 24(1): 1–12.
|
[13] |
Ekser B, Li P, Cooper DKC. Xenotransplantation: past, present, and future[J]. Curr Opin Organ Transplant, 2017, 22(6): 513–521.
|
[14] |
Cooper DKC, Pierson RN 3rd, Hering BJ, et al. Regulation of clinical xenotransplantation-time for a reappraisal[J]. Transplantation, 2017, 101(8): 1766–1769. doi: 10.1097/TP.0000000000001683
|
[15] |
Higginbotham L, Mathews D, Breeden CA, et al. Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model[J]. Xenotransplantation, 2015, 22(3): 221–230. doi: 10.1111/xen.12166
|
[16] |
Cooper DKC, Ezzelarab MB, Hara H. Low anti-pig antibody levels are key to the success of solid organ xenotransplantation: But is this sufficient?[J]. Xenotransplantation, 2017, 24(6): 1–6.
|
[17] |
Lai L, Kolber-Simonds D, Park KW, et al. Production of alpha- 1,3-galactosyltransferase knockout pigs by nuclear transfer cloning[J]. Science, 2002, 295(5557): 1089–1092. doi: 10.1126/science.1068228
|
[18] |
Dai Y, Vaught TD, Boone J, et al. Targeted disruption of the alpha1, 3-galactosyltransferase gene in cloned pigs[J]. Nat Biotechnol, 2002, 20(3): 251–255. doi: 10.1038/nbt0302-251
|
[19] |
McGregor CGA, Ricci D, Miyagi N, et al. Human CD55 expression blocks hyperacute rejection and restricts complement activation in Gal knockout cardiac xenografts[J]. Transplantation, 2012, 93(7): 686–692. doi: 10.1097/TP.0b013e3182472850
|
[20] |
McGregor C, Byrne G, Rahmani B, et al. Physical equivalency of wild type and galactose α 1,3 galactose free porcine pericardium; a new source material for bioprosthetic heart valves[J]. Acta Biomater, 2016, 41: 204–209. doi: 10.1016/j.actbio.2016.06.007
|
[21] |
Mohiuddin MM, Corcoran PC, Singh AK, et al. B-cell depletion extends the survival of GTKO.hCD46Tg pig heart xenografts in baboons for up to 8 months[J]. Am J Transplant, 2012, 12(3): 763–771. doi: 10.1111/j.1600-6143.2011.03846.x
|
[22] |
Chen G, Qian H, Starzl T, et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys[J]. Nat Med, 2005, 11(12): 1295–1298. doi: 10.1038/nm1330
|
[23] |
Byrne GW, Du Z, Stalboerger P, et al. Cloning and expression of porcine 1,4 N-acetylgalactosaminyl transferase encoding a new xenoreactive antigen[J]. Xenotransplantation, 2014, 21(6): 543–554. doi: 10.1111/xen.2014.21.issue-6
|
[24] |
Lee W, Hara H, Ezzelarab MB, et al. Initial in vitro studies on tissues and cells from GTKO/CD46/NeuGcKO pigs[J]. Xenotransplantation, 2016, 23(2): 137–150. doi: 10.1111/xen.2016.23.issue-2
|
[25] |
Burlak C, Bern M, Brito AE, et al. N-linked glycan profiling of GGTA1/CMAH knockout pigs identifies new potential carbohydrate xenoantigens[J]. Xenotransplantation, 2013, 20(5): 277–291. doi: 10.1111/xen.2013.20.issue-5
|
[26] |
Petersen B, Frenzel A, Niemann H. Efficient generation of a triple knockout (GGTA1/CMAH/ASGR1) of xenorelevant genes in pig fibroblasts[J]. Xenotransplantation, 2015, 22(Suppl S1): S40.
|
[27] |
Estrada JL, Martens G, Li P, et al. Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1/CMAH/4GalNT2 genes[J]. Xenotransplantation, 2015, 22(3): 194–202. doi: 10.1111/xen.2015.22.issue-3
|
[28] |
Zhang RJ, Wang Y, Chen L, et al. Reducing immunoreactivity of porcine bioprosthetic heart valves by genetically-deleting three major glycan antigens, GGTA1/4GalNT2/CMAH[J]. Acta Biomater, 2018, 72: 196–205. doi: 10.1016/j.actbio.2018.03.055
|
[29] |
Wang ZY, Martens GR, Blankenship RL, et al. Eliminating xenoantigen expression on swine RBC[J]. Transplantation, 2017, 101(3): 517–523. doi: 10.1097/TP.0000000000001302
|
[30] |
Amano S, Shimomura N, Kaji Y, et al. Antigenicity of porcine cornea as xenograft[J]. Curr Eye Res, 2003, 26(6): 313–318. doi: 10.1076/ceyr.26.5.313.15440
|
[31] |
Hara H, Koike N, Long C, et al. Initial in vitro investigation of the human immune response to corneal cells from genetically engineered pigs[J]. Invest Ophthalmol Vis Sci, 2011, 52(8): 5278–5286. doi: 10.1167/iovs.10-6947
|
1. | Lackamp N, Wilkemeyer I, Jelas I, et al. Survey of Long-Term Experiences of Sperm Cryopreservation in Oncological and Non-Oncological Patients: Usage and Reproductive Outcomes of a Large Monocentric Cohort. Front Oncol, 2021, 11: 772809. DOI:10.3389/fonc.2021.772809 |